Stock listing
BSE:LALPATHLAB Dr. Lal PathLabs Limited Share Price
Indian listing (BSE) of Dr. Lal PathLabs Limited · home listing NSE:LALPATHLAB
Follow Dr. Lal PathLabs Limited into a list and get an email when it puts out news.
Home listing price · NSE:LALPATHLAB
₹2,006.00 INR +40.60 (+2.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:LALPATHLAB
- Day range
- ₹1,940.00 – ₹2,028.20 INRNov 20, 2026
- Volume
- 264,951 sharesNov 20, 2026
- Market cap
- ₹335.4B INRAt the close on Nov 20, 2026 · price × 167.2M shares outstanding
- 52-week range
- ₹1,272.60 – ₹2,079.00 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹554.8M INRMedian day 227,612 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:LALPATHLAB · Home | ₹2,006.00 INR | +40.60 (+2.1%) | 264,951 | ₹1,950.00 | ₹2,028.20 | ₹1,940.00 | ₹1,965.40 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:LALPATHLAB · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹2,006.00 | +40.60 | +2.1% | ₹1,950.00 | ₹2,028.20 | ₹1,940.00 | 264,951 | |
| ₹1,965.40 | -14.80 | -0.7% | ₹1,972.30 | ₹1,998.30 | ₹1,950.00 | 185,918 | |
| ₹1,980.20 | -20.50 | -1.0% | ₹1,997.00 | ₹2,015.50 | ₹1,971.20 | 107,613 | |
| ₹2,000.70 | +7.70 | +0.4% | ₹1,982.00 | ₹2,025.30 | ₹1,966.20 | 214,277 | |
| ₹1,993.00 | -15.80 | -0.8% | ₹2,008.80 | ₹2,025.00 | ₹1,977.00 | 144,590 | |
| ₹2,008.80 | -19.90 | -1.0% | ₹2,028.70 | ₹2,049.00 | ₹1,998.10 | 234,264 | |
| ₹2,028.70 | +12.20 | +0.6% | ₹2,040.00 | ₹2,065.00 | ₹2,016.00 | 540,291 | |
| ₹2,016.50 | +46.50 | +2.4% | ₹2,008.80 | ₹2,079.00 | ₹1,990.10 | 340,155 | |
| ₹1,970.00 | +3.20 | +0.2% | ₹1,962.00 | ₹2,011.00 | ₹1,935.00 | 566,941 | |
| ₹1,966.80 | -62.60 | -3.1% | ₹2,049.00 | ₹2,061.90 | ₹1,944.50 | 552,700 | |
| ₹2,029.40 | +103.70 | +5.4% | ₹1,934.10 | ₹2,049.00 | ₹1,901.00 | 735,423 | |
| ₹1,925.70 | +38.50 | +2.0% | ₹1,887.20 | ₹1,936.00 | ₹1,877.20 | 231,854 | |
| ₹1,887.20 | -19.20 | -1.0% | ₹1,906.40 | ₹1,914.90 | ₹1,856.50 | 150,836 | |
| ₹1,906.40 | -5.30 | -0.3% | ₹1,911.70 | ₹1,958.00 | ₹1,886.00 | 282,549 | |
| ₹1,911.70 | -10.60 | -0.6% | ₹1,925.00 | ₹1,925.00 | ₹1,890.10 | 208,641 | |
| ₹1,922.30 | +20.50 | +1.1% | ₹1,885.20 | ₹1,936.50 | ₹1,871.00 | 124,179 | |
| ₹1,901.80 | +46.20 | +2.5% | ₹1,848.00 | ₹1,913.90 | ₹1,821.30 | 273,785 | |
| ₹1,855.60 | +17.40 | +0.9% | ₹1,844.00 | ₹1,867.00 | ₹1,797.80 | 467,078 | |
| ₹1,838.20 | +3.20 | +0.2% | ₹1,839.00 | ₹1,854.60 | ₹1,801.20 | 119,250 | |
| ₹1,835.00 | +5.00 | +0.3% | ₹1,835.00 | ₹1,857.60 | ₹1,824.10 | 349,768 | |
| ₹1,830.00 | -0.10 | 0.0% | ₹1,843.70 | ₹1,873.10 | ₹1,819.90 | 291,322 | |
| ₹1,830.10 | -28.90 | -1.6% | ₹1,856.00 | ₹1,876.10 | ₹1,828.40 | 190,469 | |
| ₹1,859.00 | -26.00 | -1.4% | ₹1,880.00 | ₹1,907.90 | ₹1,851.90 | 245,047 | |
| ₹1,885.00 | -47.00 | -2.4% | ₹1,934.00 | ₹1,936.80 | ₹1,856.80 | 218,448 | |
| ₹1,932.00 | +19.00 | +1.0% | ₹1,910.60 | ₹1,942.00 | ₹1,887.10 | 223,891 | |
| ₹1,913.00 | -56.80 | -2.9% | ₹1,969.70 | ₹1,988.70 | ₹1,893.00 | 95,924 | |
| ₹1,969.80 | +39.90 | +2.1% | ₹1,933.00 | ₹2,002.50 | ₹1,930.00 | 191,545 | |
| ₹1,929.90 | +32.10 | +1.7% | ₹1,898.90 | ₹1,942.80 | ₹1,882.80 | 167,905 | |
| ₹1,897.80 | -40.20 | -2.1% | ₹1,945.10 | ₹1,961.00 | ₹1,888.00 | 271,926 | |
| ₹1,938.00 | -14.00 | -0.7% | ₹1,952.50 | ₹1,970.00 | ₹1,930.70 | 254,536 | |
| ₹1,952.00 | -17.00 | -0.9% | ₹1,993.20 | ₹2,018.70 | ₹1,945.90 | 245,709 | |
| ₹1,969.00 | -26.00 | -1.3% | ₹2,005.90 | ₹2,026.00 | ₹1,960.00 | 350,211 | |
| ₹1,995.00 | +12.00 | +0.6% | ₹1,975.70 | ₹2,027.60 | ₹1,936.20 | 542,969 | |
| ₹1,983.00 | +37.00 | +1.9% | ₹1,946.00 | ₹1,994.00 | ₹1,865.00 | 525,994 | |
| ₹1,946.00 | -13.40 | -0.7% | ₹1,943.60 | ₹1,971.40 | ₹1,930.60 | 401,450 | |
| ₹1,959.40 | +11.40 | +0.6% | ₹1,952.30 | ₹1,965.20 | ₹1,907.50 | 137,296 | |
| ₹1,948.00 | -9.00 | -0.5% | ₹1,980.00 | ₹1,986.80 | ₹1,902.70 | 452,137 | |
| ₹1,957.00 | +27.00 | +1.4% | ₹1,940.00 | ₹1,976.20 | ₹1,911.70 | 430,163 | |
| ₹1,930.00 | +22.70 | +1.2% | ₹1,903.00 | ₹1,930.00 | ₹1,890.00 | 230,347 | |
| ₹1,907.30 | +5.00 | +0.3% | ₹1,920.40 | ₹1,944.00 | ₹1,903.10 | 262,090 | |
| ₹1,902.30 | +9.80 | +0.5% | ₹1,896.90 | ₹1,935.00 | ₹1,896.90 | 214,308 | |
| ₹1,892.50 | -34.50 | -1.8% | ₹1,930.10 | ₹1,959.40 | ₹1,885.00 | 477,275 | |
| ₹1,927.00 | +39.20 | +2.1% | ₹1,890.60 | ₹1,941.10 | ₹1,888.00 | 354,166 | |
| ₹1,887.80 | -3.20 | -0.2% | ₹1,921.00 | ₹2,038.60 | ₹1,870.00 | 1,560,989 | |
| ₹1,891.00 | -6.00 | -0.3% | ₹1,907.00 | ₹1,921.00 | ₹1,885.50 | 171,214 | |
| ₹1,897.00 | -15.00 | -0.8% | ₹1,900.00 | ₹1,924.60 | ₹1,893.90 | 224,876 | |
| ₹1,912.00 | -4.00 | -0.2% | ₹1,917.20 | ₹1,927.00 | ₹1,880.90 | 165,825 | |
| ₹1,916.00 | +13.00 | +0.7% | ₹1,905.20 | ₹1,962.00 | ₹1,901.20 | 205,022 | |
| ₹1,903.00 | +3.00 | +0.2% | ₹1,881.40 | ₹1,920.00 | ₹1,881.40 | 90,505 | |
| ₹1,900.00 | +5.00 | +0.3% | ₹1,880.00 | ₹1,913.00 | ₹1,870.10 | 191,362 | |
| ₹1,895.00 | -32.00 | -1.7% | ₹1,920.50 | ₹1,925.20 | ₹1,855.70 | 288,144 | |
| ₹1,927.00 | +13.00 | +0.7% | ₹1,927.20 | ₹1,934.90 | ₹1,902.30 | 168,643 | |
| ₹1,914.00 | +14.80 | +0.8% | ₹1,904.40 | ₹1,933.60 | ₹1,893.10 | 178,401 | |
| ₹1,899.20 | -58.60 | -3.0% | ₹1,934.80 | ₹1,938.90 | ₹1,873.80 | 468,711 | |
| ₹1,957.80 | +31.40 | +1.6% | ₹1,931.10 | ₹1,963.00 | ₹1,884.60 | 157,780 | |
| ₹1,926.40 | -13.60 | -0.7% | ₹1,938.50 | ₹1,946.80 | ₹1,916.10 | 90,724 | |
| ₹1,940.00 | -2.00 | -0.1% | ₹1,942.00 | ₹1,948.80 | ₹1,908.60 | 87,929 | |
| ₹1,942.00 | +29.20 | +1.5% | ₹1,900.00 | ₹1,946.50 | ₹1,885.00 | 134,265 | |
| ₹1,912.80 | +13.80 | +0.7% | ₹1,893.80 | ₹1,929.80 | ₹1,875.10 | 194,732 | |
| ₹1,899.00 | +10.00 | +0.5% | ₹1,890.00 | ₹1,911.60 | ₹1,876.00 | 146,775 | |
| ₹1,889.00 | +1.00 | +0.1% | ₹1,894.00 | ₹1,914.80 | ₹1,880.00 | 99,702 | |
| ₹1,888.00 | +3.50 | +0.2% | ₹1,901.30 | ₹1,908.00 | ₹1,873.40 | 308,167 |
Splits
1 split · NSE:LALPATHLAB · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split |
- Ticker
- BSE:LALPATHLAB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- BSE
- Currency
- INR
What changed lately
Latest news release · Nov 4, 2026
Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated November 04, 2026, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2026".
Latest deck · Nov 4, 2026
Q2 FY27 Earnings Presentation
Earnings · 31 slides
Latest news
Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated November 04, 2026, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2026".
Nov 4, 2026
Closed ₹2,029.40 (+5.4%) on Nov 4, 2026
Dr. Lal Pathlabs Limited Press Release Jul 24 2026
Jul 24, 2026
Closed ₹1,775.00 (+5.5%) on Jul 24, 2026
Press Release Apr 30 2026
Apr 30, 2026
Closed ₹1,564.00 (+13.8%) on May 4, 2026
Press Release Jan 30 2026
Jan 30, 2026
Closed ₹1,425.00 (+1.9%) on Feb 1, 2026
Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India
Jan 7, 2026
Closed ₹1,437.70 (-2.2%) on Jan 8, 2026
Press Release Jan 06 2026
Jan 6, 2026
Closed ₹1,470.00 (-0.7%) on Jan 7, 2026
Dr. Lal Pathlabs Limited Press Release Jan 06 2026
Jan 5, 2026
Closed ₹1,480.00 (-2.0%) on Jan 6, 2026
Press Release Nov 26 2025
Nov 26, 2025
Closed ₹1,560.00 (+0.5%) on Nov 27, 2025
Dr. Lal Pathlabs Limited Press Release Nov 26 2025
Nov 25, 2025
Closed ₹1,551.50 (-0.9%) on Nov 26, 2025
Dr. Lal PathLabs Limited on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 9 in the last 12 months · 33 in all · newest Nov 4, 2026 · oldest 2020
- Decks
- 98 decks · latest Nov 4, 2026
Where Dr. Lal PathLabs Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:LALPATHLAB · Home listing | NSE | India | INR |
| BSE:LALPATHLAB · This page | BSE | India | INR |
Valuation
P/E 57.5× against a median of 46.0×: 5th lowest of 8 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹321.7B INR
- P/E
- 57.5×
- EV/sales
- 10.6×
- EV/EBITDA
- 36.0×
- Price/book
- 12.2×
- Gross margin
- 54.6%
- Operating margin
- 23.6%
- Net margin
- 19.2%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Dr. Lal PathLabs Limited · NSE:LALPATHLAB | US$3.62B | US$3.47B | 57.5× | 10.6× | 36.0× | 12.2× | 19.2% | 0.1× | n/a |
| Global Health Limited · NSE:MEDANTA | US$4.29B | US$4.28B | 64.3× | 7.9× | 35.5× | 9.2× | 12.2% | 0.3× | n/a |
| Narayana Hrudayalaya Ltd. · NSE:NH | US$4.26B | US$4.59B | 46.0× | 4.1× | 22.4× | 7.9× | 8.4% | 1.2× | n/a |
| Bumrungrad Hospital Public Co., Ltd. · SET:BH | US$4.17B | US$3.96B | 18.6× | 5.3× | 13.5× | 5.2× | 29.8% | 0.0× | n/a |
| Jointown Pharmaceutical Group Co., Ltd. Class A · SSE:600998 | US$3.91B | US$755.9M | 13.3× | 0.0× | n/a | 0.9× | 1.1% | 0.1× | n/a |
| Doximity, Inc. · NYSE:DOCS | US$3.66B | US$2.95B | 26.2× | 4.5× | 15.3× | 3.9× | 21.1% | 0.0× | 0.74 |
| Krishna Institute of Medical Sciences Limited · NSE:KIMS | US$3.61B | US$3.93B | 157× | 7.9× | 41.0× | 8.5× | 4.6% | 0.9× | n/a |
| Surgery Partners, Inc. · NASDAQ:SGRY | US$3.50B | US$6.21B | n/a | 1.9× | 11.5× | 2.1× | −2.6% | 1.8× | 0.94 |
| Hims & Hers Health, Inc. · NYSE:HIMS | US$3.30B | US$4.15B | n/a | 1.4× | n/a | 9.3× | −6.7% | 4.4× | 2.64 |
| Acadia Healthcare Company, Inc. · NASDAQ:ACHC | US$3.22B | US$5.41B | n/a | 1.6× | 10.1× | 1.6× | −33.1% | 1.2× | 0.82 |
| Privia Health Group, Inc. · NASDAQ:PRVA | US$3.20B | US$2.76B | 92.1× | 1.1× | 43.3× | 3.9× | 1.4% | 0.0× | 0.23 |
| Median of the others | US$3.63B | US$4.05B | 46.0× | 3.0× | 18.9× | 4.6× | 3.0% | 0.6× | 0.82 |
Forecasts
Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.
- Price target
- 2210.15 INR · Analysts' mean
- EPS, year to Mar 2027
- 39.43 · 22 analysts
- Revenue, year to Mar 2027
- 32.69B · 21 analysts
Events
- Next results
- Feb 5, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Nov 4, 2026 · Before open | +5.4% |
| Q1 2027 | Jul 24, 2026 · Before open | +5.5% |
| Q4 2026 | Apr 30, 2026 · Before open | −1.7% |
| Q3 2026 | Jan 30, 2026 · Before open | +0.3% |
| Q2 2026 | Oct 31, 2025 · Before open | +1.6% |
| Q1 2026 | Jul 31, 2025 · Before open | +1.6% |
| Q4 2025 | Apr 25, 2025 · Before open | −0.5% |
| Q3 2025 | Jan 30, 2025 · Before open | +4.5% |
| Q2 2025 | Oct 23, 2024 · Before open | −1.8% |
| Q1 2025 | Aug 7, 2024 · Before open | +5.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | May 10, 2024 · Before open | +5.5% |
| Q3 2024 | Feb 1, 2024 · Before open | −0.2% |
| Q2 2024 | Nov 2, 2023 · Before open | +3.4% |
| Q1 2024 | Jul 27, 2023 · Before open | +3.3% |
| Q4 2023 | May 11, 2023 · Before open | −2.2% |
| Q3 2023 | Feb 2, 2023 · Before open | −1.7% |
| Q2 2023 | Nov 8, 2022 · Before open | −8.2% |
| Q1 2023 | Jul 28, 2022 · Before open | −1.4% |
| Q4 2022 | May 17, 2022 | −7.8% |
| Q3 2022 | Feb 10, 2022 · Before open | −0.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY27 Earnings Presentation | Earnings | 31 slides | Nov 4, 2026 |
| Q1 FY2027 Earnings Presentation | Earnings | 30 slides | Jul 24, 2026 |
| Q4 FY26 Earnings Presentation | Earnings | 31 slides | Apr 30, 2026 |
| Q3 FY26 Earnings Presentation | Earnings | 42 slides | Jan 30, 2026 |
| Q2 FY26 Earnings Presentation | Earnings | 41 slides | Oct 31, 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 39 slides | Jul 31, 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 38 slides | July 2025 |
| Q4 FY2025 Earnings Presentation | Earnings | 40 slides | Apr 25, 2025 |
| Q3 FY25 Earnings Presentation | Earnings | 30 slides | Jan 30, 2025 |
| Q2 FY25 Earnings Presentation | Earnings | 31 slides | Oct 23, 2024 |
Show 50 decks
This page holds 50 of 98 decks. Open Decks
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.6B | 24.6B | 22.3B | 20.2B | 20.9B | 15.8B | 13.3B | 12.0B | 10.6B | 9.12B |
| Cost of revenue | 16.0B | 8.23B | 7.64B | 7.29B | 5.02B | 6.02B | -1.46B | -1.50B | -1.37B | -1.18B |
| Gross profit | 11.6B | 16.4B | 14.6B | 12.9B | 15.9B | 9.80B | 14.8B | 13.5B | 11.9B | 10.3B |
| Research and development | 38.8M | 36.0M | 33.9M | |||||||
| Selling, general and administrative | 2.75B | 3.42B | 3.13B | 2.82B | 2.85B | 2.04B | 1.73B | 1.51B | 1.28B | 1.00B |
| Operating income | 6.21B | 5.60B | 4.67B | 3.51B | 7.37B | 3.64B | 4.45B | 4.13B | 3.63B | 3.15B |
| Depreciation and amortization | 1.62B | 1.42B | 1.44B | 1.50B | 1.08B | 772.0M | 728.1M | 382.2M | 330.6M | 275.4M |
| EBITDA | 7.83B | 7.02B | 6.10B | 5.02B | 8.45B | 4.42B | 5.18B | 4.51B | 3.96B | 3.43B |
| Interest expense | 228.0M | 223.0M | 293.6M | 375.3M | 301.7M | 160.0M | 153.1M | 8.39M | 8.41M | 6.98M |
| Income before tax | 6.69B | 6.25B | 5.05B | 3.44B | 4.75B | 3.94B | 3.11B | 3.01B | 2.61B | 2.37B |
| Income tax | 1.59B | 1.33B | 1.43B | 1.03B | 1.25B | 979.3M | 829.2M | 1.00B | 895.3M | 812.4M |
| Net income | 5.05B | 4.87B | 3.58B | 2.39B | 3.45B | 2.92B | 2.26B | 1.99B | 1.71B | 1.55B |
| Earnings per share, basic | 30.20 | 29.20 | 21.49 | 28.73 | 41.57 | 35.25 | 13.68 | 24.15 | 20.82 | 18.95 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.43B | 2.93B | 3.61B | 2.64B | 3.78B | 2.44B | 1.97B | 1.29B | 200.5M | 150.5M |
| Short-term investments | 10.9B | 8.71B | 5.82B | 5.87B | 3.03B | 7.40B | 5.35B | 5.44B | 4.35B | 3.28B |
| Receivables | 1.48B | 1.24B | 1.10B | 722.0M | 1.23B | 1.07B | 725.5M | 1.11B | 1.39B | 487.0M |
| Inventory | 439.0M | 361.0M | 373.1M | 338.0M | 525.4M | 425.6M | 569.6M | 285.4M | 273.4M | 179.1M |
| Current assets | 15.7B | 13.6B | 11.3B | 9.73B | 8.75B | 11.5B | 8.93B | 8.14B | 6.23B | 5.11B |
| Property, plant and equipment | 3.39B | 3.47B | 4.04B | 4.30B | 3.12B | 3.02B | 1.64B | 1.69B | 1.24B | |
| Goodwill | 5.48B | 5.48B | 5.48B | 5.48B | 5.50B | 853.6M | 772.3M | 279.7M | 312.2M | 592.9M |
| Total assets | 31.5B | 27.2B | 24.6B | 23.9B | 23.5B | 16.6B | 13.7B | 10.9B | 9.19B | 7.64B |
| Accounts payable | 1.81B | 1.99B | 1.87B | 1.56B | 1.47B | 1.44B | 1.18B | 798.0M | 654.5M | 523.6M |
| Current liabilities | 4.51B | 4.03B | 4.65B | 4.70B | 5.00B | 2.74B | 2.27B | 1.38B | 1.16B | 736.6M |
| Long-term debt | 0 | 0 | 833.0M | 1.67B | 1.00M | 0 | ||||
| Total debt | 1.99B | 1.57B | 2.47B | 4.20B | 5.33B | 1.50B | 1.29B | 1.29B | ||
| Total liabilities | 6.05B | 5.10B | 5.71B | 6.86B | 8.10B | 3.85B | 3.20B | 1.40B | 1.24B | 1.02B |
| Shareholders' equity | 25.1B | 21.7B | 18.5B | 16.7B | 15.1B | 12.5B | 10.3B | 9.45B | 7.91B | 6.60B |
| Shares outstanding | 167.2M | 166.8M | 166.5M | 83.1M | 82.9M | 82.7M | 165.1M | 82.5M | 82.0M | 81.6M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 7.02B | 5.69B | 5.35B | 4.56B | 4.47B | 3.98B | 2.84B | 2.19B | 1.97B | 1.72B |
| Capital spending | -1.67B | -443.0M | -511.7M | -446.0M | -4.76B | -595.9M | -796.2M | -420.4M | -724.7M | -515.9M |
| Free cash flow | 5.35B | 5.25B | 4.84B | 4.11B | -294.5M | 3.39B | 2.04B | 1.76B | 1.25B | 1.20B |
| Cash from investing | -4.88B | -3.03B | -242.7M | -2.87B | -4.49B | -2.12B | -261.1M | -997.4M | -1.72B | -1.41B |
| Cash from financing | -2.63B | -3.34B | -4.14B | -2.83B | 1.36B | -1.39B | -1.90B | -552.6M | 125.0M | -344.5M |
| Dividends paid | -2.23B | -2.07B | -2.01B | -1.03B | -1.17B | -994.8M | -1.56B | -551.9M | -318.4M | -378.0M |
| Share buybacks | 127.0M | 34.9M | -720.0M | 1.09B | 3.00M | 1.66M | -30.0K | -310.0K | 39.1M | |
| Change in cash | 6.16B | -683.3M | 972.0M | -1.15B | 1.34B | 475.8M | 673.3M | 635.4M | 372.9M | -34.8M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated November 04, 2026, titled "Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2026". | Nov 4, 2026 | Results | NSE India |
| Dr. Lal Pathlabs Limited Press Release Jul 24 2026 | Jul 24, 2026 | Other filings | NSE India |
| Press Release Apr 30 2026 | Apr 30, 2026 | Results | NSE India |
| Press Release Jan 30 2026 | Jan 30, 2026 | Results | NSE India |
| Dr. Lal Pathlabs Limited Press Release Jan 06 2026 | Jan 5, 2026 | Other filings | NSE India |
| Dr. Lal Pathlabs Limited Press Release Nov 26 2025 | Nov 25, 2025 | Other filings | NSE India |
| Press Release Oct 31 2025 | Oct 31, 2025 | Results | NSE India |
| Press Release Aug 20 2025 | Aug 20, 2025 | Other filings | NSE India |
| Press Release Jul 31 2025 | Jul 31, 2025 | Results | NSE India |
| Press Release Jun 25 2025 | Jun 25, 2025 | Other filings | NSE India |
All 30 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Apr 25 2025 | Apr 25, 2025 | Other filings | NSE India |
| Press Release Apr 15 2025 | Apr 15, 2025 | Other filings | NSE India |
| Press Release Jan 30 2025 | Jan 30, 2025 | Results | NSE India |
| Press Release Oct 23 2024 | Oct 23, 2024 | Other filings | NSE India |
| Press Release Aug 07 2024 | Aug 7, 2024 | Results | NSE India |
| Press Release May 10 2024 | May 10, 2024 | Results | NSE India |
| Press Release Feb 01 2024 | Feb 1, 2024 | Results | NSE India |
| Press Release Nov 02 2023 | Nov 2, 2023 | Results | NSE India |
| Press Release Jul 27 2023 | Jul 27, 2023 | Results | NSE India |
| Press Release May 11 2023 | May 11, 2023 | Results | NSE India |
| Press Release Feb 02 2023 | Feb 2, 2023 | Quarterly report | NSE India |
| Press Release Nov 08 2022 | Nov 8, 2022 | Other filings | NSE India |
| Press Release Jul 28 2022 | Jul 28, 2022 | Results | NSE India |
| Press Release May 17 2022 | May 17, 2022 | Results | NSE India |
| Press Release Feb 10 2022 | Feb 10, 2022 | Results | NSE India |
| Press Release Oct 26 2021 | Oct 26, 2021 | Other filings | NSE India |
| Press Release Jul 30 2021 | Jul 30, 2021 | Other filings | NSE India |
| Press Release May 21 2021 | May 21, 2021 | Other filings | NSE India |
| Press Release Jan 29 2021 | Jan 29, 2021 | Results | NSE India |
| Press Release Nov 06 2020 | Nov 6, 2020 | Results | NSE India |
Cap table
Built by 6ix from Dr. Lal PathLabs Limited’s releases
- Common shares
- 167,210,720
- Fully diluted
- 167,210,720
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 167,210,720 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 167,210,720 |
Log in to ask 6ix AI your own questions about Dr. Lal PathLabs Limited.